0:00
30:42
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.
Otros episodios de "Goldman Sachs Talks"
No te pierdas ningún episodio de “Goldman Sachs Talks”. Síguelo en la aplicación gratuita de GetPodcast.